Table 2. The 5-year recurrence, recurrence-free survival and overall survival rates based on pretransplant alpha-fetoprotein level.
| Study, First author | Alpha-fetoprotein level | 5-year recurrence rate, % | 5-year recurrence-free survival rate, % | 5-year overall survival rate, % |
| Hameed | >1000 ng/mL | - | 52.7 | - |
| <1000 ng/mL | - | 80.3 | - | |
| Duvoux | <100 ng/mL | 16.2 | - | 67.5 |
| >100-1000 ng/mL | 26.8 | - | 51.1 | |
| 1000 ng/mL | 53 | - | 39.1 | |
| Hangzhou | ≤400 ng/mL | - | 62.4 | 70.7 |
| Lai | ≤400 ng/mL and/or tumor diameter ≤8 cm | 4.9 | 74.4 | - |
| Toso | ≤400 ng/mL and TTV <115 cm3 | - | - | 74.6 (4-year) |